Yahoo España Búsqueda web

Search results

  1. ASH is the world’s largest professional society of clinicians and scientists who are dedicated to conquering blood diseases. Learn about ASH research, education, publications, advocacy, and membership programs.

    • Log in or create an account

      The American Society of Hematology (ASH) is the world’s...

    • Research

      A joint effort of the American Society of Hematology (ASH)...

    • Education

      Conversations in Hematology Education is a brand-new podcast...

    • Advocacy

      ASH is the leader in representing the interests of...

    • Careers

      ASH provides support to hematologists in all stages of their...

    • Program and Schedule

      Schedule and Program for the 2023 ASH Meeting on Hematologic...

    • Newsroom

      ASH, the world's largest professional society concerned with...

    • ASH Membership

      Join a diverse community of more than 18,000 hematologists...

  2. 15 de nov. de 2022 · 6 Department of Internal Medicine, Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH 15 The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Division of Hematology, Columbus, OH

  3. 15 de nov. de 2022 · Conclusions: In this cohort study there was a response to treatment at 6 weeks in 57% of patients with AIHA and 92% with ITP. For both AIHA and ITP none of the initial treatment types or patient characteristics showed significant differences in likelihood of response.

  4. 2 de nov. de 2023 · The Genomic and Transcriptomic Landscape of Myeloid Sarcoma and Associated Acute Myeloid Leukemia | Blood | American Society of Hematology. 617.Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis | November 2, 2023.

  5. 2 de nov. de 2023 · Genomic Profiles and Associated Survival Prognosticators in Black Patients with Acute Myeloid Leukemia | Blood | American Society of Hematology. 617.Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis | November 2, 2023.

  6. Plenary Scientific Session. Program: General Sessions. Sunday, December 10, 2023: 2:00 PM-4:00 PM. Hall A (San Diego Convention Center) Co-chairs: Robert A. Brodsky, MD, Johns Hopkins University and Mohandas Narla, DSc, New York Blood Center Enterprises. Disclosures: